• 1
    Chua HC, Venketasubramanian N, Tjia H, et al. Elimination of phenytoin in toxic overdose. Clin Neurol Neurosurg 2000;102: 68.
  • 2
    Martin E, Gambertoglio JG, Adler DS, et al. Removal of phenytoin by hemodialysis in uremic patients. JAMA 1977;238: 17503.
  • 3
    Dasgupta A, Abu-Alfa A. Increased free phenytoin concentrations in predialysis serum compared to postdialysis serum in patients with uremia treated with hemodialysis: role of uremic compounds. Am J Clin Pathol 1992;98: 1925.
  • 4
    Frenchie D, Bastani B. Significant removal of phenytoin during high flux dialysis with cellulose triacetate dialyzer. Nephrol Dial Transplant 1998;13: 8178.
  • 5
    Kawasaki C, Nishi R, Uekihara S, et al. Charcoal hemoperfusion in the treatment of phenytoin overdose. Am J Kidney Dis 2000;35: 3236.
  • 6
    Stange J, Mitzner SR, Risler T, Erley A, et al. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999;23: 31930.
  • 7
    Winkler SR, Luer MS. Antiepileptic drug review: part 1. Surg Neurol 1998;49: 44952.
  • 8
    Lindow J, Wijdicks EF. Phenytoin toxicity associated with hypoalbuminemia in critically ill patients. Chest 1994;105: 6024.
  • 9
    Burt M, Anderson DC, Kloss J, et al. Evidence-based implementation of free phenytoin therapeutic drug monitoring. Clin Chem 2000;46: 11325.
  • 10
    Liu CS, Wu HM, Kao SH, et al. Phenytoin-mediated oxidative stress in serum of female epileptics: a possible pathogenesis in the fetal hydantoin syndrome. Hum Exp Toxicol 1997;16: 17781.
  • 11
    Litovitz TL, Klein-Schwartz W, White S, et al. 2000 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2001;19: 33795.